Xiaqiu Qiu
Affiliations: | Max Planck Institute for Molecular Physiology |
Google:
"Xiaqiu Qiu"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Borgelt L, Haacke N, Lampe P, et al. (2022) Small-molecule screening of ribonuclease L binders for RNA degradation. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 154: 113589 |
| Goebel GL, Qiu X, Wu P. (2022) Kinase-targeting small-molecule inhibitors and emerging bifunctional molecules. Trends in Pharmacological Sciences |
| Hwang J, Qiu X, Borgelt L, et al. (2022) Synthesis and evaluation of RNase L-binding 2-aminothiophenes as anticancer agents. Bioorganic & Medicinal Chemistry. 58: 116653 |
| Goebel GL, Hohnen L, Borgelt L, et al. (2021) Small molecules with tetrahydroquinoline-containing Povarov scaffolds as inhibitors disrupting the Protein-RNA interaction of LIN28-let-7. European Journal of Medicinal Chemistry. 228: 114014 |
| Qiu X, Li Y, Yu B, et al. (2020) Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion. European Journal of Medicinal Chemistry. 211: 113091 |
| Weng T, Qiu X, Wang J, et al. (2017) Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy. European Journal of Medicinal Chemistry. 143: 656-669 |
| Wang J, Ge R, Qiu X, et al. (2017) Discovery and synthesis of novel Wogonin derivatives with potent antitumor activity in vitro. European Journal of Medicinal Chemistry. 140: 421-434 |